Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations
   

EFPIA Newsletter 23 April 2020

 
 
 
   

#WeWontRest in the fight against COVID-19
 
 
 
 
   

News and statements
 

230420 Europe’s COVID-19 battle: Getting the data we need to ensure the supply of medicines...
23 April 2020

A major part of the solution is the provision of detailed, accurate forecasting data from the European Centre for Disease... Read more

23042019 The route out from under the cloud of coronavirus
23 April 2020

EFPIA statement on the European Council Meeting and the EU Roadmap for Recovery Read more

Exscalate4Cov project: Call for Collaboration by DG Connect
20 April 2020

The European Commission (DG Connect) is looking for industry partners to join the Exscalate4Cov project, seeking to... Read more

19042020 Open letter to Members of the European Parliament in response to EP resolution of...
19 April 2020

As an industry, we continue to stand shoulder to shoulder with citizens, patients, health systems, Member States and... Read more

19042020 Europe’s COVID-19 battle: Ensuring the supply of medicines and the continuity of clinical...
19 April 2020

EFPIA member companies are continuing to work around the clock to increase capacity and ensure the supply of critical... Read more
 
 
 
   

Blogs
 

Europe’s fight against COVID-19: Seeing the best in people
30 April 2020 - Nathalie Moll

Like any war, we have witnessed the heart ache and damage it causes – with over 100,000 lives lost across Europe. But... Read more

As an intensive care doctor, I could not wait and do nothing. It runs through my veins: I wanted...
23 April 2020

Yacir Fannan is an Infectious Disease Medical Affairs Specialist at MSD France, based in Marseille. In the last weeks,... Read more

We must modestly make our contribution and stick together to express our spirit of solidarity...
23 April 2020

Philippe Mariot has been a Medical Affairs Associate Director for MSD since April 2019; he is responsible for the development... Read more

The COVID-19 “Regulatory Road to Innovation”
21 April 2020 - Sini Eskola

Lessons learned on optimising Research, Development and Regulatory Processes Read more

COVID-19 and Cancer: Handling uncertainty – Working Together
21 April 2020 - Deepak Khanna

In times where we need each other’s skills, where there is a big unmet need, not only against COVID-19, we should also... Read more
 
 
 
   

As we stay apart....
 
...pharmaceutical companies are coming together to research new vaccines, diagnostics and treatments to tackle this pandemic.
... Read more
...pharmaceutical companies are coming together to ensure the supply of medicines to the patients that need them
... Read more
...pharmaceutical companies are coming together to support people on the frontline
... Read more
The European research-based pharmaceutical industry’s commitment to tackling COVID-19
... Read more
 
 
 
   

Missed our first two virtual events? Watch them again!
 

Europe COVID-19 battle: The pharmaceutical industry response
20 April 2020 (Virtual event)

With Europe at the epicentre of the COVID-19 pandemic, we want to give partners and health stakeholders around Europe... Read more

Cancer and COVID-19 "Short-Term Reality, Long-Term Vision"
22 April 2020 (Online event)

What does the current situation mean for cancer patients in terms of access to care, new medicines, and timely diagnosis?... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu
EFPIA 2024 All rights reserved Disclaimer